摘要
当比较男性,冠状动脉心脏疾病(CHD)和这些转到血管重建术,包括经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)手 术的女性有显著的差异。妇女的冠状动脉较小,因此产生了PCI和CABG程序更多的挑战。女性会混淆诊断应对急性冠脉综合征(ACS)独 特的非典型症状,女性出了名的推迟寻求ACS的医疗帮助,以及医生和其他照顾者有一种尽量减少这些症状的重要意义的倾向,进一步的延 迟了必要的照顾。那里还似乎是炎症和冠心病在妇女的一种增加的关联。年轻的女病人冠心病,高死亡率和病死率明显超过男性患者。对于 心血管(CV)风险防范的妇女,他汀类药物有与其使用有关的争议,但总体而言,有益的结果源于他汀类药物的证据也是对女性有效)。据 报道在PCI和CABG手术后的妇女,不良后果的发生率增加。这些糟糕的临床结果都在当代几年发生,但因进步微创技术减少)。然而,PCI, 可以提高在谁拥有高风险的ACS是女性的临床结果,不幸的是,在一个不那么频繁的基础上进行,此外,还有涉及女性与男性相比,存在更 大的延迟。随着复杂CHD的妇女增加有关临床合并症,较低的解剖学SYNTAX评分(来自:与红豆杉和心脏外科[语法]审判经皮冠状动脉介 入治疗之间的协同作用),为了使妇女获得了类似的长期死亡率受益,似乎有必要CABG手术与PCI手术相比较。
关键词: 心血管疾病,冠状动脉旁路移植手术,雌性激素,抗炎,经皮冠状动脉介入治疗,他丁类药物
Current Medicinal Chemistry
Title:Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Volume: 22 Issue: 31
Author(s): Thomas F. Whayne and Debabrata Mukherjee
Affiliation:
关键词: 心血管疾病,冠状动脉旁路移植手术,雌性激素,抗炎,经皮冠状动脉介入治疗,他丁类药物
摘要: There are significant differences in coronary heart disease (CHD) in women whenever a comparison is made to men and these carry over to revascularization procedures including percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery. The coronary arteries of women are smaller, which presents additional challenges for PCI and CABG procedures. Unique atypical symptomatology in response to acute coronary syndrome (ACS) in women can confound diagnosis, women notoriously delay seeking medical help for ACS, and physicians and other caregivers have had a tendency to minimize the significance of these symptoms, contributing further to a delay in necessary care. There also appears to be an increased association of inflammation and CHD in women. The younger the female patient with CHD, the higher the mortality and that mortality clearly exceeds that of comparable male patients. For cardiovascular (CV) risk prevention in women, statins have had controversy associated with their use but overall, the proof of beneficial outcomes results from statins is also valid in women. An increased rate of adverse outcomes has been reported in women after PCI and CABG surgery. These worse clinical outcomes have persisted in contemporary years but lessened due to advancement in invasive techniques. Nevertheless, PCI that could improve clinical outcomes in women who have high-risk ACS is, unfortunately, performed on a less frequent basis and, in addition, there are greater delays involving women as compared to men. With increased clinical comorbidity associated with complex CHD in women, a lower anatomical SYNTAX score (from: SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery [SYNTAX] trial) appears necessary in order for women to achieve a similar long-term mortality benefit from CABG surgery as compared to PCI.
Export Options
About this article
Cite this article as:
Thomas F. Whayne and Debabrata Mukherjee , Unique Coronary Artery Disease Differences in Women as Related to Revascularization, Current Medicinal Chemistry 2015; 22 (31) . https://dx.doi.org/10.2174/0929867322666151001122007
DOI https://dx.doi.org/10.2174/0929867322666151001122007 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Therapeutic Targeting of P-Selectin in Atherosclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Diagnosis and Prognosis of Fetal Cardiomyopathies: A Review
Current Pharmaceutical Design Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular Disease
Current Vascular Pharmacology Long-term Etanercept Therapy Favors Weight Gain and Ameliorates Cachexia in Rheumatoid Arthritis Patients: Roles of Gut Hormones and Leptin
Current Pharmaceutical Design Human Clinical Studies of Tea Polyphenols in Allergy or Life Style-related Diseases
Current Pharmaceutical Design Aging and Remodeling During Healing of the Wounded Heart: Current Therapies and Novel Drug Targets
Current Drug Targets Structural, Biochemical and Non-Traditional Cardiovascular Risk Markers in PCOS
Current Pharmaceutical Design Directed Differentiation of Pluripotent Cells Towards Therapeutic Stem Cells
Recent Patents on Regenerative Medicine Mesenchymal Stromal Cells: A Promising Cell Source for the Treatment of Inflammatory Cardiomyopathy
Current Pharmaceutical Design Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
Current Drug Targets Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Pulmonary Hypertension secondary to Left Heart Disease
Current Vascular Pharmacology In-Vitro and In-Vivo Pharmacological Activities with Phytochemical Evaluation of Methanolic Extract of Microcos paniculata Stem Barks
Current Drug Therapy Chronic Obstructive Pulmonary Disease and Asthma and the Risk of Mild Cognitive Impairment and Dementia: A Population Based CAIDE Study
Current Alzheimer Research Beta-Blockers are Associated with Decreased In-Hospital Mortality and Stroke in Acute Decompensated Heart Failure: Findings from a Retrospective Analysis of a 22-Year Registry in the Middle East (1991-2013)
Current Vascular Pharmacology Apolipoprotein A-I/HDL Infusion Therapy for Plaque Stabilization-Regression: A Novel Therapeutic Approach
Current Pharmaceutical Design Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics
Current Respiratory Medicine Reviews From the Deepest Sea Shelf to the Uppermost Kitchen Cabinet Shelf: The Quest for Novel TNF-α Inhibitors
Current Topics in Medicinal Chemistry